{
  "id": 1402,
  "text": "A mild peripheral toxicity, usually completely reversible, was infrequently seen after AK-2123 administration.# 13.1.4 Brachytherapy A meta-analysis1237 (four studies1238-1241) showed no significant differences between high dose rate and low dose rate intracavity brachytherapy in combination with EBRT when considering OS, DSS, RFS, local control rate, recurrence, metastasis and treatment related complications for women with LACC.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: A mild peripheral toxicity, usually completely reversible, was infrequently seen after AK-2123 administration.# 13.1.4 Brachytherapy A meta-analysis1237 (four studies1238-1241) showed no significant differences between high dose rate and low dose rate intracavity brachytherapy in combination with EBRT when considering OS, DSS, RFS, local control rate, recurrence, metastasis and treatment related c\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在宫颈癌的治疗中，腔内近距离治疗（即近距离放射治疗）与外部放射治疗（EBRT）的联合使用是一种重要的策略。根据现有的研究和meta分析，使用高剂量率或低剂量率的腔内近距离治疗对于包括总生存期、疾病特异性生存期、无复发生存期、局部控制率、复发、转移以及治疗相关的并发症等多个方面都没有显著差异。尽管如此，腔内近距离治疗具有一些独特的重要性。\n\n首先，近距离治疗可以更精确地将放射线集中在肿瘤区域，从而最大化地破坏癌细胞并减少对周围健康组织的损伤。其次，这种治疗方法提高了局部肿瘤控制的效果。对于某些患者而言，特别是在难以完全切除或无法接受手术的情况下，近距离治疗提供了一种有效的局部治疗介入。最后，结合EBRT时，近距离治疗可以帮助改善治疗的整体效果并有助于减少复发的风险。\n\n总体而言，腔内近距离治疗在宫颈癌治疗中的价值在于它能够以较高的精准度和有效性来攻击肿瘤，同时其剂量率选择的灵活性意味着可以根据患者的具体情况进行个性化调整，以达到最佳治疗效果。",
  "query": "在使用AK-2123后偶尔出现轻度的外周毒性。根据meta分析，EBRT联合高剂量或低剂量率的腔内近距离治疗在总生存期、疾病特异性生存期、无复发生存期、局部控制率、复发、转移和治疗相关并发症方面没有显著差异。这个近距离治疗策略在宫颈癌治疗中有什么重要性？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在使用AK-2123后偶尔出现轻度的外周毒性。根据meta分析，EBRT联合高剂量或低剂量率的腔内近距离治疗在总生存期、疾病特异性生存期、无复发生存期、局部控制率、复发、转移和治疗相关并发症方面没有显著差异。这个近距离治疗策略在宫颈癌治疗中有什么重要性？\n\n<reference text>: A mild peripheral toxicity, usually completely reversible, was infrequently seen after AK-2123 administration.# 13.1.4 Brachytherapy A meta-analysis1237 (four studies1238-1241) showed no significant differences between high dose rate and low dose rate intracavity brachytherapy in combination with EBRT when considering OS, DSS, RFS, local control rate, recurrence, metastasis and treatment related complications for women with LACC.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在宫颈癌的治疗中，腔内近距离治疗（即近距离放射治疗）与外部放射治疗（EBRT）的联合使用是一种重要的策略。根据现有的研究和meta分析，使用高剂量率或低剂量率的腔内近距离治疗对于包括总生存期、疾病特异性生存期、无复发生存期、局部控制率、复发、转移以及治疗相关的并发症等多个方面都没有显著差异。尽管如此，腔内近距离治疗具有一些独特的重要性。\n\n首先，近距离治疗可以更精确地将放射线集中在肿瘤区域，从而最大化地破坏癌细胞并减少对周围健康组织的损伤。其次，这种治疗方法提高了局部肿瘤控制的效果。对于某些患者而言，特别是在难以完全切除或无法接受手术的情况下，近距离治疗提供了一种有效的局部治疗介入。最后，结合EBRT时，近距离治疗可以帮助改善治疗的整体效果并有助于减少复发的风险。\n\n总体而言，腔内近距离治疗在宫颈癌治疗中的价值在于它能够以较高的精准度和有效性来攻击肿瘤，同时其剂量率选择的灵活性意味着可以根据患者的具体情况进行个性化调整，以达到最佳治疗效果。"
}